Catalyst Wire Dossier Catalyst Wire Dossier

(R)-roscovitine (seliciclib)

roscovitine · Cyclacel Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for (R)-roscovitine (seliciclib), covering 2025-12-12 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation [Phase 2]

See pricing